Moneycontrol
HomeNewsTrendsCOVID-19 | IIT alumni launch philanthropic initiative to raise funds for medical infrastructure
Trending Topics

COVID-19 | IIT alumni launch philanthropic initiative to raise funds for medical infrastructure

The alumni groups have come together to provide critical medical equipment like oxygen concentrators, cylinders, para monitor machines and other support supplies to government hospitals.

May 15, 2021 / 16:04 IST
Story continues below Advertisement
A patient suffering from the coronavirus infection receives treatment inside the emergency ward at Holy Family hospital in New Delhi. (Image: Reuters)

India is facing an unprecedented crisis due to the COVID-19 second wave and the nation’s healthcare infrastructure has stretched to the limit. Hospitals across the country are facing a shortage of beds, medical oxygen and other life-saving supplies as COVID-19 cases continue to surge on a daily basis. Various non-governmental organisations (NGOs) are already working round the clock along with the central and state government agencies, to save the lives of people battling the disease.

Most hospitals in the country are already working at full capacity. Against this backdrop, a group of Indian Institutes of Technology (IIT) alumni has launched a philanthropic initiative to raise funds to improve the country’s medical infrastructure and medical oxygen availability.

Story continues below Advertisement

They started the ‘Help Indian Hospitals’ initiative on April 24, 2021, on milaap.org, a crowd-funding platform. The initiative is also supported by civil servants.

At present, the highest demand is for oxygen and oxygen-generating devices like oxygen concentrators. The alumni groups have come together to provide critical medical equipment like oxygen concentrators, cylinders, BiPAP, CPAP, para monitor machines and other support supplies to government hospitals so that they are equipped to handle the deluge of patients.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show